Cancer Cell Line: NCI-H2122
- Aliases: NCI-H2122, NCIH2122, H2122, CVCL_1531
- Tissue: Lung
- Cellosaurus: CVCL_1531
NCI-H2122 is in CellMinerCDB, a searchable tool integrating cancer cell line pharmacogenomics data to link gene and drug activity signatures.
Click Here to Access CellMinerCDB
If you use content from this page or CellMinerCDB, please cite: Luna A et al. 2021. PMID: 33196823, Rajapakse VN et al. 2018. PMID: 30553813, and Luna et al. 2016., PMID: 33196823.
Available Data
Visit CellMinerCDB to interactively explore available pharmacogenomics data for the lung cancer cell line: NCI-H2122.
Broad Achilles
- CRISPR
- Miscellaneous Phenotypic
Broad CCLE
- DNA Copy Number
- DNA Methylation RRBS
- DNA Mutation
- Drug Activity
- Metabolomics
- Microarray RNA Expression using z-score
- MicroRNA
- Miscellaneous Phenotypic
- RNA-seq Expression using log2.FPKM+1
- RPLA Protein
Broad CTRP
- DNA Copy Number
- DNA Mutation
- Drug Activity
- Microarray RNA Expression using z-score
- Miscellaneous Phenotypic
Broad Prism
- Drug Activity
MDACC CLP
- RPLA Protein
Sanger/MGH GDSC
- DNA Copy Number
- DNA Methylation 450K
- DNA Mutation
- Drug Activity
- Microarray RNA Expression using z-score
- Miscellaneous Phenotypic
Technical Information
This page was generated using the R package rcellminer 2.15.1.